Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 506 entries
View as:

Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01489670 Org: User:
Start: 09/30/11 End: 03/31/13 Due: 03/31/14

Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02043145 Org: User:
Start: 07/31/08 End: 04/30/12 Due: 04/30/13

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

Phase: N/A Priority: Normal
NCT ID: NCT03426345 Org: User:
Start: 02/16/18 End: 07/16/20 Due: 07/16/21

CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT00836017 Org: User:
Start: 01/31/09 End: 08/31/13 Due: 08/31/14

Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT02313454 Org: User:
Start: 11/17/14 End: 04/08/15 Due: 04/08/16

A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines

Phase: N/A Priority: Normal
NCT ID: NCT01749410 Org: User:
Start: 05/31/13 End: 05/31/14 Due: 05/31/15

Chronic Migraine Epidemiology and Outcomes Study

Phase: N/A Priority: Normal
NCT ID: NCT01648530 Org: User:
Start: 07/31/12 End: 11/30/13 Due: 11/30/14

Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

Phase: N/A Priority: Normal
NCT ID: NCT03091439 Org: User:
Start: 05/15/17 End: 08/31/17 Due: 08/31/18

Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01579084 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Phase: N/A Priority: Normal
NCT ID: NCT01391273 Org: User:
Start: 07/01/11 End: 05/19/12 Due: 05/19/13

Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale

Phase: N/A Priority: Normal
NCT ID: NCT01412086 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada

Phase: N/A Priority: Normal
NCT ID: NCT04567589 Org: User:
Start: 09/30/20 End: 02/28/21 Due: 02/28/22

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Phase: N/A Priority: Normal
NCT ID: NCT01231334 Org: User:
Start: 08/31/10 End: 06/30/11 Due: 06/30/12

Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT01107392 Org: User:
Start: 08/01/10 End: 06/08/12 Due: 06/08/13

Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT01475253 Org: User:
Start: 11/30/11 End: 12/31/12 Due: 12/31/13

BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT03320850 Org: User:
Start: 10/04/17 End: 07/21/20 Due: 07/21/21

Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT00651729 Org: User:
Start: 04/30/03 End: 12/31/04 Due: 12/31/05

Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs

Phase: N/A Priority: Normal
NCT ID: NCT02145650 Org: User:
Start: 05/31/14 End: 08/31/15 Due: 08/31/16

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00284518 Org: User:
Start: 12/31/05 End: 05/31/10 Due: 05/31/11

Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function

Phase: N/A Priority: Normal
NCT ID: NCT00972374 Org: User:
Start: 11/30/09 End: 07/31/11 Due: 07/31/12

A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

Phase: N/A Priority: Normal
NCT ID: NCT02553772 Org: User:
Start: 01/06/16 End: 09/09/16 Due: 09/09/17

Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)

Phase: N/A Priority: Normal
NCT ID: NCT01027650 Org: User:
Start: 03/31/10 End: 02/28/13 Due: 02/28/14

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01664949 Org: User:
Start: 01/31/13 End: 05/31/14 Due: 05/31/15

A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT01903720 Org: User:
Start: 07/16/13 End: 03/30/15 Due: 03/30/16

Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01987765 Org: User:
Start: 01/31/09 End: 09/30/12 Due: 09/30/13